Reaction

Pulmonary Valve Disease reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 129 reports · 2 co-occurring drugs

As of the last recalculation, Pulmonary Valve Disease appears in 129 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is TELMISARTAN (PRR 280.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Telmisartan25280.1280.5
Linagliptin25274.1274.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.